Epidarex Capital
2026-09-03epidarex.com
Overview
What they do
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
epidarex.com
What they look for
We identify and fund transformative life science opportunities in emerging and under-ventured research hubs within the US and UK. We often partner with leading universities and research institutions to provide much needed capital for their most innovative ideas.
epidarex.com
Stage
Seed, Series A
epidarex.com
Sectors
Healthcare
epidarex.com
Based
Bethesda, US
epidarex.com
Sources
2026-09-03epidarex.comEPIDAREX IS A TRANSATLANTIC VENTURE CAPITAL FIRM LED BY A DIVERSE TEAM OF EARLY-STAGE…
2026-09-03epidarex.comUK Office. 137a George Street Edinburgh United Kingdom, EH2 4JY Tel: +44 (0)131 243 3700. GET…
2026-09-03epidarex.comEpidarex's transatlantic portfolio includes Apellis Pharmaceuticals, Enterprise Therapeutics…
2026-09-03epidarex.comA. Sinclair Dunlop, Managing Partner Kyparissia (Kyp) Sirinakis, Founding Partner Dr.…
2026-09-03epidarex.comEdinburgh, UK and Bethesda, MD, USA, 27 January 2026, Epidarex Capital (“Epidarex”), a…
2026-09-03globenewswire.comEdinburgh, UK and Bethesda, MD, USA, 27 January 2026, Epidarex Capital (“Epidarex”), a…
Portfolio, cheque size and the rest
The 12 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.